Nicholas G. Avgeropoulos

2.3k total citations
19 papers, 711 citations indexed

About

Nicholas G. Avgeropoulos is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Nicholas G. Avgeropoulos has authored 19 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Neurology. Recurrent topics in Nicholas G. Avgeropoulos's work include Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (6 papers) and Cancer Treatment and Pharmacology (3 papers). Nicholas G. Avgeropoulos is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (6 papers) and Cancer Treatment and Pharmacology (3 papers). Nicholas G. Avgeropoulos collaborates with scholars based in United States, France and Switzerland. Nicholas G. Avgeropoulos's co-authors include Tracy T. Batchelor, William R. Tyor, Cheryl H. Baker, Santhi D. Konduri, George C. Bobustuc, Arati Limaye, Gary S. Pearl, Edward L. Hogan, Sridharan Gururangan and Roger E. McLendon and has published in prestigious journals such as Journal of Clinical Oncology, Neurosurgery and Journal of the Neurological Sciences.

In The Last Decade

Nicholas G. Avgeropoulos

18 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas G. Avgeropoulos United States 10 418 234 179 113 99 19 711
David Cachia United States 16 401 1.0× 157 0.7× 215 1.2× 157 1.4× 88 0.9× 59 738
Terri Chew United States 5 358 0.9× 203 0.9× 189 1.1× 151 1.3× 146 1.5× 5 857
Eva María Corrales-García Spain 7 375 0.9× 270 1.2× 118 0.7× 94 0.8× 215 2.2× 12 754
Michael Tobias United States 12 223 0.5× 320 1.4× 76 0.4× 106 0.9× 96 1.0× 30 777
Sameh Geha Canada 15 219 0.5× 210 0.9× 122 0.7× 94 0.8× 117 1.2× 30 747
Takeshi Takayasu Japan 20 564 1.3× 228 1.0× 176 1.0× 157 1.4× 139 1.4× 69 1.0k
Yuriko Minn United States 4 578 1.4× 341 1.5× 233 1.3× 167 1.5× 227 2.3× 5 997
Aria Jamshidi United States 11 210 0.5× 120 0.5× 78 0.4× 64 0.6× 65 0.7× 44 524
Ichiyo Shibahara Japan 19 576 1.4× 255 1.1× 187 1.0× 168 1.5× 181 1.8× 73 1.0k
Donita Lightner United States 7 571 1.4× 375 1.6× 224 1.3× 99 0.9× 265 2.7× 14 1.1k

Countries citing papers authored by Nicholas G. Avgeropoulos

Since Specialization
Citations

This map shows the geographic impact of Nicholas G. Avgeropoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas G. Avgeropoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas G. Avgeropoulos more than expected).

Fields of papers citing papers by Nicholas G. Avgeropoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas G. Avgeropoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas G. Avgeropoulos. The network helps show where Nicholas G. Avgeropoulos may publish in the future.

Co-authorship network of co-authors of Nicholas G. Avgeropoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas G. Avgeropoulos. A scholar is included among the top collaborators of Nicholas G. Avgeropoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas G. Avgeropoulos. Nicholas G. Avgeropoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Khagi, Simon, Rupesh Kotecha, Na Tosha Gatson, et al.. (2024). Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma. The Oncologist. 30(2). 10 indexed citations
2.
3.
4.
Kumthekar, Priya, Michael Youssef, Amir Azadi, et al.. (2022). BIOM-05. THE HER2 FLIP: HER2 AMPLIFICATION OF TUMOR CELLS IN THE CEREBROSPINAL FLUID (CSF-TCS) OF PATIENTS WITH SOLID TUMOR LEPTOMENINGEAL METASTASIS. Neuro-Oncology. 24(Supplement_7). vii4–vii5. 4 indexed citations
5.
6.
7.
Raizer, Jeffrey J., Sean Grimm, Marta Peñas-Prado, et al.. (2015). A phase I trial everolimus and sorafenib in patients with recurrent high-grade gliomas: Brain Tumor Treatment Collaborative trial 09-01.. Journal of Clinical Oncology. 33(15_suppl). 2061–2061. 1 indexed citations
8.
Puduvalli, Vinay K., Jing Wu, Ying Yuan, et al.. (2015). Brain Tumor Trials Collaborative Bayesian Adaptive Randomized Phase II trial of bevacizumab plus vorinostat versus bevacizumab alone in adults with recurrent glioblastoma (BTTC-1102).. Journal of Clinical Oncology. 33(15_suppl). 2012–2012. 9 indexed citations
9.
Avgeropoulos, Nicholas G., et al.. (2014). Glioblastoma: Background, Standard Treatment Paradigms, and Supportive Care Considerations. The Journal of Law Medicine & Ethics. 42(2). 171–182. 75 indexed citations
10.
Wu, Shandong, et al.. (2013). Computer-assisted identification and volumetric quantification of dynamic contrast enhancement in brain MRI: an interactive system. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 8674. 867407–867407. 1 indexed citations
11.
Reddy, K. Krishna, et al.. (2012). Confidence guided enhancing brain tumor segmentation in multi-parametric MRI. Journal of International Crisis and Risk Communication Research. 2879. 366–369. 17 indexed citations
12.
Avgeropoulos, Nicholas G., et al.. (2010). Cerebral amyloidoma mimicking intracranial tumor: a case report. Journal of Medical Case Reports. 4(1). 308–308. 13 indexed citations
13.
Bobustuc, George C., Cheryl H. Baker, Arati Limaye, et al.. (2010). Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro-Oncology. 12(9). 917–927. 125 indexed citations
14.
Field, Melvin, et al.. (2009). Markers Distinguishing Cancer Stem Cells from Normal Human Neuronal Stem Cell Populations in Malignant Glioma Patients. Neurosurgery. 65(2). 426–426. 1 indexed citations
15.
Quinn, Jennifer A., David A. Reardon, Allan H. Friedman, et al.. (2003). Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma. Journal of Clinical Oncology. 21(4). 646–651. 182 indexed citations
16.
Tyor, William R., et al.. (2002). Treatment of spinal cord impact injury in the rat with transforming growth factor-β. Journal of the Neurological Sciences. 200(1-2). 33–41. 66 indexed citations
17.
Shields, Donald C., Nicholas G. Avgeropoulos, Naren L. Banik, & William R. Tyor. (2000). Acute Multiple Sclerosis Characterized by Extensive Mononuclear Phagocyte Infiltration. Neurochemical Research. 25(11). 1517–1520. 7 indexed citations
18.
Avgeropoulos, Nicholas G. & Tracy T. Batchelor. (1999). New Treatment Strategies for Malignant Gliomas. The Oncologist. 4(3). 209–224. 137 indexed citations
19.
Avgeropoulos, Nicholas G., et al.. (1998). Potential Relationships Between the Presence of HIV, Macrophages, and Astrogliosis in SCID Mice with HIV Encephalitis. PubMed. 2(1). 1–20. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Cachia Breakdown of academic impact, for papers by Terri Chew Breakdown of academic impact, for papers by Eva María Corrales-García Breakdown of academic impact, for papers by Michael Tobias Breakdown of academic impact, for papers by Sameh Geha Breakdown of academic impact, for papers by Takeshi Takayasu Breakdown of academic impact, for papers by Yuriko Minn Breakdown of academic impact, for papers by Aria Jamshidi Breakdown of academic impact, for papers by Ichiyo Shibahara Breakdown of academic impact, for papers by Donita Lightner
Rankless by CCL
2026